The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. COPAXONE PEN contains the active ingredient glatiramer acetate.

Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector Sarclisa administered via the CirCLIQ ® OBI offers a treatment experience ...

(NEXSTAR) – GLP-1 drugs, which have grown incredibly popular in recent years for their ability to help people lose substantial weight, are now friendlier to needle-phobes. The class of medications, ...

April 13 (Reuters) - Teva Pharmaceutical (TEVA.TA), opens new tab must face a lawsuit claiming it used unlawful methods to block generic competition for its multiple sclerosis drug Copaxone, a New ...

Osteoarthritis affects around 600 million people globally. It causes pain, stiffness and reduced joint function – most commonly in the knees, hands and hips. There’s currently no cure for ...

Knee osteoarthritis is a complex disease that affects the whole joint, including bone, cartilage, ligaments and muscles. Osteoarthritis is a common cause of pain and movement difficulty, affecting 8.3 ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points to the benefits of taking these medications. Traditionally, patients ...

In the Phase 2 IZALCO study, we evaluated efficacy, patient preference, safety and pharmacokinetics for isatuximab administered SC by an innovative on-body injector (OBI) or manual injection, plus ...

As with other drugs, Copaxone (glatiramer acetate) can cause side effects, such as weight gain, skin rash, and injection site reactions. If side effects of Copaxone become difficult to tolerate, talk ...

AHMEDABAD, India--(BUSINESS WIRE)--Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and ...

Please provide your email address to receive an email when new articles are posted on . Recommendations for outcomes that fall between results with manual injection and autoinjectors come from the FDA ...